(NASDAQ: PHIO) Phio Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 105.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,340.75%.
Phio Pharmaceuticals's earnings in 2026 is -$10,932,000.On average, 4 Wall Street analysts forecast PHIO's earnings for 2026 to be -$16,293,193, with the lowest PHIO earnings forecast at -$15,938,867, and the highest PHIO earnings forecast at -$16,467,452.
In 2027, PHIO is forecast to generate -$9,124,188 in earnings, with the lowest earnings forecast at -$10,360,264 and the highest earnings forecast at -$7,684,811.